Radiation-delivering microspheres developed by Sirtex are as effective as Nexavar (sorafenib) chemotherapy against a liver cancer known as hepatocellular carcinoma (HCC),…
Articles by Alice Melao
Candidate drug EDP-305 reduced fibrosis progression and improved non-alcoholic fatty liver disease (NAFLD) and primary biliary cholangitis (PBC) disease settings in…
The latest preclinical results of Ocera Therapeutics’ ammonia scavenger OCR-002 showed that it can reduce fibrosis progression in animal…
Galectin Therapeutics’s lead drug GR-MD-02 may be a promising therapeutic approach to treat fibrosis in fatty liver disease — or non-alcoholic…
A subset of stem cell-derived immune cells, known as iPS-ML, stopped tumor progression and improved survival of mice with liver…
The transforming growth factor-beta (TGF-beta) protein promotes the conversion of normal liver cells to cancerous cells, a study indicates. It also…
A healthy diet and regular physical exercise were found to influence the levels of circulating fatty acids, a type of…
Researchers from Stony Brook University have described a biochemical mechanism that occurs in the liver and is responsible for…